Success Metrics

Clinical Success Rate
97.7%

Based on 42 completed trials

Completion Rate
98%(42/43)
Active Trials
4(8%)
Results Posted
55%(23 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
8
15%
Ph early_phase_1
3
6%
Ph phase_3
3
6%
Ph phase_1
3
6%
Ph not_applicable
21
40%
Ph phase_4
11
21%

Phase Distribution

6

Early Stage

8

Mid Stage

14

Late Stage

Phase Distribution49 total trials
Early Phase 1First-in-human
3(6.1%)
Phase 1Safety & dosage
3(6.1%)
Phase 2Efficacy & side effects
8(16.3%)
Phase 3Large-scale testing
3(6.1%)
Phase 4Post-market surveillance
11(22.4%)
N/ANon-phased studies
21(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

97.7%

42 of 43 finished

Non-Completion Rate

2.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

52

all time

Status Distribution
Active(6)
Completed(42)
Terminated(1)
Other(3)

Detailed Status

Completed42
unknown3
Recruiting3
Not yet recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
52
Active
4
Success Rate
97.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (6.1%)
Phase 13 (6.1%)
Phase 28 (16.3%)
Phase 33 (6.1%)
Phase 411 (22.4%)
N/A21 (42.9%)

Trials by Status

not_yet_recruiting24%
active_not_recruiting12%
unknown36%
completed4281%
recruiting36%
terminated12%

Recent Activity

Clinical Trials (52)

Showing 20 of 52 trialsScroll for more
NCT07714200Not Applicable

Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness

Not Yet Recruiting
NCT00494728Phase 1

Smoking Cessation for Depressed Smokers

Active Not Recruiting
NCT05628389Not Applicable

Phone Enabled Implementation of Cessation Support

Recruiting
NCT01990079Not Applicable

Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD

Completed
NCT01789710Not Applicable

Contingency Management for Smoking Cessation in Homeless Smokers

Completed
NCT04965181Not Applicable

Mindfulness-based Smoking Cessation Enhanced With Mobile Technology

Completed
NCT05723588Phase 2

Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD

Recruiting
NCT04590404Phase 3

Metabolism Informed Smoking Treatment: The MIST RCT

Completed
NCT05030766Phase 4

Testing Integrative Smoking Cessation for HIV Patients

Completed
NCT06931054Not Applicable

Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation

Recruiting
NCT05095779Phase 2

Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties

Completed
NCT04063267Phase 2

Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder

Completed
NCT00113074Not Applicable

Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers

Completed
NCT06063421Not Applicable

Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan

Not Yet Recruiting
NCT01329614Early Phase 1

Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving

Completed
NCT00888459Phase 2

A Pilot Study Evaluating Nicotine Lozenges and Self Help

Completed
NCT05740098Not Applicable

Financial Incentives for Smoking Cessation Among Mothers

Completed
NCT04135937Phase 4

Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)

Completed
NCT03626064Not Applicable

The PROMPT Pilot Study

Completed
NCT02721082Phase 4

Changing the Default for Tobacco Treatment

Completed

Drug Details

Intervention Type
DRUG
Total Trials
52